Table 1

Inclusion criteria

Respondents

Definition


Medical thought leader

Initial list identification:

• Individuals involved in breast cancer medicine with a history of significant publications and presentations at major medical and scientific symposia

• Heads of leading local medical schools and/or research-based teaching hospitals or cancer centers

• Leaders of local societies relevant to breast cancer medicine or members of national cancer study groups, breast cancer research councils, or tumor boards

• Individuals with an active and wide publication history or those who had made presentations within the past few years at the American Society of Clinical Oncology (ASCO), St. Gallen, and the San Antonio Breast Cancer Symposium (SABCS)

The list was then cross-checked to assess if these clinicians were:

• Heads of local leading medical schools and/or research-based teaching hospitals or cancer centers; and/or

• Leaders of breast cancer medical or other relevant medical societies responsible for breast cancer medicine; and/or

• Members of national cancer study groups, breast cancer research councils, and/or national tumor boards.


Policy maker

The selection of policy thought leaders was based on:

• Information obtained from the Ministries of Health which recommended the appropriate personnel in charge of breast cancer policy, funding, screening, and public education

• In most cases, nomination and/or validation by the medical thought leaders and/or advocacy leaders.


Patient advocacy leader

Advocacy leader selection came from:

• Referrals by medical or public policy thought leaders; and/or

• Independent internet searches and media citations; and/or

• Other advocacy leaders both domestically and internationally.


Bridges et al. BMC Health Services Research 2011 11:227   doi:10.1186/1472-6963-11-227

Open Data